These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35688954)

  • 1. Preferences of Sjögren's syndrome patients regarding potential new saliva substitutes.
    Assy Z; Bikker FJ; Mashhour E; Asadi M; Brand HS
    Clin Oral Investig; 2022 Oct; 26(10):6245-6252. PubMed ID: 35688954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome.
    van der Reijden WA; van der Kwaak H; Vissink A; Veerman EC; Amerongen AV
    Arthritis Rheum; 1996 Jan; 39(1):57-63. PubMed ID: 8546739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.
    Alpöz E; Güneri P; Onder G; Cankaya H; Kabasakal Y; Köse T
    Clin Oral Investig; 2008 Jun; 12(2):165-72. PubMed ID: 18000691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the management of dry mouth: topical therapies.
    Furness S; Worthington HV; Bryan G; Birchenough S; McMillan R
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008934. PubMed ID: 22161442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome.
    Klestov AC; Webb J; Latt D; Schiller G; McNamara K; Young DY; Hobbes J; Fetherston J
    Oral Surg Oral Med Oral Pathol; 1981 Jun; 51(6):594-9. PubMed ID: 7019805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva as a potential tool for diagnosis of dry mouth including Sjögren's syndrome.
    Ohyama K; Moriyama M; Hayashida JN; Tanaka A; Maehara T; Ieda S; Furukawa S; Ohta M; Imabayashi Y; Nakamura S
    Oral Dis; 2015 Mar; 21(2):224-31. PubMed ID: 24750447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral manifestations of Sjögren's syndrome.
    Mathews SA; Kurien BT; Scofield RH
    J Dent Res; 2008 Apr; 87(4):308-18. PubMed ID: 18362310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of xerostomia in primary Sjögren's syndrome.
    Wall GC; Magarity ML; Jundt JW
    Pharmacotherapy; 2002 May; 22(5):621-9. PubMed ID: 12013361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.
    Aliko A; Alushi A; Tafaj A; Isufi R
    Rheumatol Int; 2012 Sep; 32(9):2877-81. PubMed ID: 21898068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes.
    Visch LL; Gravenmade EJ; Schaub RM; Van Putten WL; Vissink A
    Int J Oral Maxillofac Surg; 1986 Aug; 15(4):395-400. PubMed ID: 3091718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for dry mouth and hyposalivation in Sjögren's syndrome: A systematic review and meta-analysis.
    Al Hamad A; Lodi G; Porter S; Fedele S; Mercadante V
    Oral Dis; 2019 May; 25(4):1027-1047. PubMed ID: 30086205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
    Wu AJ
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
    Márton K; Boros I; Fejérdy P; Madléna M
    J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia in Sjögren's syndrome treated with Sali-Synt. A double-blind cross-over trial.
    Kaarela K; Mutru O
    Scand J Rheumatol; 1982; 11(1):39-40. PubMed ID: 7038859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.